NL, H., JM, U., AF, S., L, F., PJ, F., DM, P., . . . 3rd, W. J. (2018). Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36(4), 326. https://doi.org/10.1200/JCO.2017.74.6651
Chicago Style (17th ed.) CitationNL, Henry, et al. "Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 36, no. 4 (2018): 326. https://doi.org/10.1200/JCO.2017.74.6651.
MLA (9th ed.) CitationNL, Henry, et al. "Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 36, no. 4, 2018, p. 326, https://doi.org/10.1200/JCO.2017.74.6651.